<- Go Home
Bruker Corporation
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
Market Cap
$6.5B
Volume
2.9M
Cash and Equivalents
$133.4M
EBITDA
$488.7M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$1.6B
Profit Margin
47.62%
52 Week High
$56.22
52 Week Low
$28.53
Dividend
0.47%
Price / Book Value
2.66
Price / Earnings
-178.34
Price / Tangible Book Value
-248.38
Enterprise Value
$8.1B
Enterprise Value / EBITDA
15.06
Operating Income
$260.5M
Return on Equity
0.43%
Return on Assets
2.70
Cash and Short Term Investments
$133.4M
Debt
$1.7B
Equity
$2.5B
Revenue
$3.5B
Unlevered FCF
$249.6M
Sector
Life Sciences Tools and Services
Category
N/A